Business Context and Reporting Period
This Form 8-K filing by Tharimmune, Inc. (THAR) covers events occurring on November 3, 2025, with the closing of transactions on November 6, 2025. The filing details a significant capital raise through a private placement involving both cash and cryptocurrency payments, alongside major changes to the company's executive leadership and board of directors.
Key Financial Metrics
- Gross Proceeds: Approximately $545 million raised from the Offerings.
- Securities Issued: 25,966,048 shares of Common Stock and 151,456,115 Pre-Funded Warrants.
- Offering Price: $3.075 per share (or $3.0749 for Pre-Funded Warrants).
- Use of Proceeds: Establishment of the "Canton Coin" treasury and funding of company operations.
- Strategic Advisor Compensation: Warrants issued equal to 5.00% of the aggregate number of shares sold on a fully diluted basis, with an exercise price of $0.001.
Material Changes
Leadership and Board Changes
- Resignations: Nancy Davis and Sanam Parikh resigned from the Board of Directors on November 6, 2025. The filing states these resignations were not due to disagreements with the Company.
- New CEO: Mark Wendland was appointed Chief Executive Officer and Director. He previously served as Partner and COO at DRW Holdings LLC.
- New President: Mark Toomey was appointed President. He previously served as Managing Director at Liberty City Ventures and Head of Distribution at Galaxy Digital.
- Former CEO Role: Sireesh Appajosyula will remain with the Company as CEO of its subsidiary, Gravitas Life Sciences, Inc.
Executive Compensation
- Mark Wendland: $500,000 annual base salary, $150,000 sign-on bonus, and eligibility for performance bonuses ($125,000 minimum for 2025; $500,000 minimum for 2026). Eligible for 1.0% of fully diluted common stock in RSUs.
- Mark Toomey: $500,000 annual base salary and eligibility for performance bonuses ($125,000 minimum for 2025; $500,000 minimum for 2026). Eligible for 0.9% of fully diluted common stock in RSUs.
- Severance: Both executives are entitled to 12 months of base salary upon termination without cause or for good reason. Mr. Wendland's severance is capped at $1,000,000 if terminated prior to the 2026 bonus payment date.
Outlook, Risks, and Contingencies
- Lock-Up Agreements: Purchasers have agreed not to sell, transfer, or hedge the securities until the resale registration statement is declared effective.
- Strategic Pivot: The proceeds are explicitly designated to establish a "Canton Coin" treasury, indicating a strategic shift or expansion into digital assets.
- Indemnification: The Company has entered into standard indemnification agreements with the new officers, potentially exposing the Company to liabilities for legal expenses and judgments.
Investor Verification Checklist
- Verify the exact composition of the "Canton Coin" treasury and the specific operational plans for the $545 million in proceeds.
- Confirm the effective date of the resale registration statement to determine when the lock-up period on the 151 million+ Pre-Funded Warrants expires.
- Review the full text of the Employment Agreements (Exhibits 10.6 and 10.7) to understand specific vesting schedules and "good reason" definitions.
- Assess the impact of the 5.00% strategic advisor warrants on future dilution.
- Clarify the relationship between Tharimmune, Inc. and the "Canton Strategic Holdings, Inc." name referenced in the request metadata, as the filing is for Tharimmune, Inc.